Clinical characteristics and predictors of in-hospital mortality in 270 consecutive patients hospitalised due to acute heart failure in a single cardiology centre during one year

Kardiologia Polska

Volumn 69, Issue 10, 2011, Pages 997-1005

  Biegus, Jan ^a   Zymliński, Robert ^a   Szachniewicz, Joanna ^a   Siwołowski, Paweł ^a   Pawluś, Aleksander ^b   Banasiak, Waldemar ^a   Jankowska, Ewa A ^a,b   Ponikowski, Piotr ^a,b  

^a 4TH MILITARY HOSPITAL   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Acute heart failure; Prognosis; Registry; Risk stratification

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; POTASSIUM;

ACUTE CORONARY SYNDROME; ACUTE HEART FAILURE; ADULT; AGED; ARTICLE; BODY WEIGHT; CLINICAL ASSESSMENT; CLINICAL PRACTICE; CREATININE BLOOD LEVEL; FEMALE; FOLLOW UP; HEART FAILURE; HEART HEMODYNAMICS; HEART RATE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; HYPERTENSION; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; POTASSIUM BLOOD LEVEL; PREDICTOR VARIABLE; PREVALENCE; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE;

EID: 80054721571     PISSN: 00229032     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Cleland JG, Swedberg K, Follath F et al. The EuroHeart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J, 2003; 24: 442-463. (Pubitemid 36286187)
2. Gheorghiade M, Abraham WT, Albert NM et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA, 2006; 296: 2217-2226. (Pubitemid 44708052)
3. Nunez J, Nunez E, Fonarow GC et al. Differential prognostic effect of systolic blood pressure on mortality according to left ventricular function in patients with acute heart failure. Eur J Heart Fail, 2010; 12: 38-44.
4. Ezekowitz JA, Bakal JA, Kaul P, Westerhout CM, Armstrong PW. Acute heart failure in the emergency department: short- and long-term outcomes of elderly patients with heart failure. Eur J Heart Fail, 2008; 10: 308-314.
5. Abraham TW, Fonarow GC, Albert NM et al. Predictors of In-Hospital Mortality in Patients Hospitalized for Heart Failure: Insights From the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF). J Am Coll Cardiol, 2008; 52; 347-356. (Pubitemid 352005813)
6. Fonarow GC, Adams KF, Abraham WT, Yancy CW, Boscardin WJ. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA, 2005; 293: 572-558.
7. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J, 2008; 29: 2388-2442.
8. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med, 1999; 130: 461-470. (Pubitemid 29135798)
9. Maggioni AP, Dahlstro U, Filippatos G et al. EURObservational Research Programme: the Heart Failure Pilot Survey (ESC-HF Pilot). Eur J Heart Fail, 2010; 12: 1076-1084.
10. Nieminen MS, Brutsaert D, Dickstein K et al. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J, 2006; 27: 2725-2736. (Pubitemid 44729876)
11. Siirila-Waris K, Lassus J, Melin J, Peuhkurinen K, Nieminen MS, Harjola V. Characteristics, outcomes, and predictors of 1-year mortality in patients hospitalized for acute heart failure. Eur Heart J, 2006; 27: 3011-3017. (Pubitemid 44950446)
12. Gheorghiade M, Rossi JS, Cotts W et al. Characterization and Prognostic Value of Persistent Hyponatremia in Patients With Severe Heart Failure in the ESCAPE Trial. Arch Intern Med, 2007; 167: 1998-2005. (Pubitemid 47606641)
13. Klein L, O'Connor CM, Leimberger JD et al. Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study. Circulation, 2005; 111: 2454-2460. (Pubitemid 40696133)
14. Metra M, Nodari S Parrinello G et al. The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT-proBNP and cardiac troponin-T. Eur J Heart Fail, 2007; 9: 776-786. (Pubitemid 47212835)
15. Jourdain P, Jondeau G, Funck F et al. Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study. J Am Coll Cardiol, 2007; 49: 1733-1739. (Pubitemid 46589928)
16. Pfisterer M, Buser P, Rickli H et al. BNP-guided vs. symptom-guided heart failure therapy the Trial of Intensified vs. Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial. JAMA, 2009; 301: 383-392.
17. Bettencourt P, Azevedo A, Pimenta J, Friões F, Ferreira S, Ferreira A. N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation, 2004; 110: 2168-2174. (Pubitemid 39372496)
18. Fonarow GC, Peacock WF, Phillips CO et al. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure. J Am Coll Cardiol, 2007; 49: 1943-1950. (Pubitemid 46694287)
19. Kubler P, Jankowska EA, Majda J Reczuch K, Banasiak W, Ponikowski P. Lack of decrease in plasma N-terminal pro-brain natriuretic peptide identifies acute heart failure patients with very poor outcome. Int J Cardiol, 2008; 129: 373-378.
20. Cohen-Solal A, Logeart D, Huang B, Cai D, Nieminen MS, Mebazaa A. Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure. J Am Coll Cardiol, 2009; 53: 2343-2348.